Clinical Trial Update: Neutropenic Sepsis in Patients With Non-Small Cell Lung Cancer Treated With Single-Agent Docetaxel and Associated Resource Use in the UK

View source ↗

Summary

A completed clinical trial evaluating neutropenic sepsis and related resource use in non-small cell lung cancer patients treated with single-agent docetaxel in …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Non-small Cell Lung Cancer

Drugs mentioned

• Taxotere (docetaxel)

Snippet

Sponsor: Hoffmann-La Roche | Conditions: Non-Small Cell Lung Cancer | Status: COMPLETED